CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 8.97 M | $353.18 M | 19.66% | 10.64% |
| CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 8.74 M | $344.15 M | 10.30% | 10.36% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 3.81 M | $150.03 M | 39.24% | 4.47% |
| BLACKROCK, INC. | 02/07/2025 | 2.76 M | $108.61 M | -1.29% | 3.27% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/28/2025 | 2.75 M | $108.07 M | -7.49% | 3.25% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/10/2025 | 2.75 M | $108.07 M | -7.47% | 3.25% |
| STATE STREET CORP | 02/14/2025 | 2.49 M | $98.07 M | -16.75% | 2.92% |
| FMR LLC | 02/13/2025 | 2.22 M | $87.51 M | -6.43% | 2.64% |
| UBS GROUP AG | 02/14/2025 | 1.98 M | $78.09 M | 194.54% | 2.33% |
| VANGUARD GROUP INC | 02/11/2025 | 1.74 M | $68.33 M | 0.61% | 2.04% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 1.59 M | $62.50 M | 0.00% | 1.86% |
| ORBIS ALLAN GRAY LTD | 02/14/2025 | 1.48 M | $58.10 M | 100.00% | 1.73% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 1.39 M | $54.68 M | 0.00% | 1.63% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.31 M | $51.48 M | 55.15% | 1.53% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 1.21 M | $47.68 M | 11.99% | 1.42% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/13/2025 | 1.05 M | $41.29 M | 0.00% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.00 M | $39.41 M | -0.73% | 1.19% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 947,301 | $37.28 M | 14.88% | 1.11% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 910,965 | $35.86 M | -3.63% | 1.08% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 893,935 | $35.19 M | 43.34% | 1.05% |
| CITADEL ADVISORS LLC | 02/14/2025 | 878,896 | $34.59 M | 69.49% | 1.03% |
| CITADEL ADVISORS LLC | 02/14/2025 | 793,700 | $31.24 M | 14.14% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 723,032 | $28.46 M | -0.17% | 0.86% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 690,191 | $27.17 M | 2.05% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 534,600 | $21.04 M | -11.59% | 0.63% |
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2025 | 498,558 | $19.62 M | 0.00% | 0.59% |
| MORGAN STANLEY | 02/14/2025 | 495,002 | $19.48 M | -21.68% | 0.58% |
| NORGES BANK | 02/12/2025 | 443,536 | $17.46 M | 100.00% | 0.53% |
| JANE STREET GROUP, LLC | 02/14/2025 | 426,817 | $16.80 M | 148.97% | 0.50% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 388,315 | $15.28 M | 8.20% | 0.46% |
| 02/11/2025 | 368,811 | $14.52 M | 100.00% | 0.44% | |
| CAPITAL ADVISORS INC/OK | 01/29/2025 | 310,270 | $12.21 M | 3.22% | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 306,272 | $12.05 M | 71.05% | 0.36% |
| CITADEL ADVISORS LLC | 02/14/2025 | 292,300 | $11.50 M | 4.39% | 0.34% |
| JPMORGAN CHASE & CO | 02/12/2025 | 289,177 | $11.38 M | -18.37% | 0.34% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 272,704 | $10.73 M | 8.96% | 0.32% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 266,500 | $10.49 M | 0.00% | 0.31% |
| NORTHERN TRUST CORP | 02/14/2025 | 257,168 | $10.12 M | 12.92% | 0.30% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2025 | 244,034 | $10.85 M | 40.17% | 0.29% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 240,444 | $9.46 M | 50.61% | 0.29% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 220,123 | $8.66 M | 8.42% | 0.26% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 208,000 | $8.19 M | 4.00% | 0.24% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 205,173 | $8.07 M | 9.86% | 0.24% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 200,000 | $7.87 M | 100.00% | 0.23% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 197,274 | $7.76 M | -5.99% | 0.23% |
| 02/14/2025 | 190,800 | $7.51 M | 100.00% | 0.22% | |
| CAPITAL INTERNATIONAL SARL | 02/13/2025 | 186,920 | $7.36 M | 9.62% | 0.22% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 166,139 | $6.54 M | -33.27% | 0.19% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 165,816 | $6.53 M | -22.55% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 165,300 | $6.51 M | -37.24% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 538 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
Versant Capital Management, Inc: 0
Mirador Capital Partners LP: 0
ARK Investment Management LLC: 8.97 M
Capital International Investors: 8.74 M
T. Rowe Price Investment Management, Inc.: 3.81 M
BlackRock, Inc.: 2.76 M
76.49% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 70.91 M shares in the last 24 months. This purchase volume represents approximately $2.42 B in transactions.